Frontiers in Cardiovascular Medicine (Apr 2024)

Pulmonary artery banding: a 20-year experience at a tertiary care center in a developing country

  • Racha Ghoussaini,
  • Rana Zareef,
  • Adham Makarem,
  • Nour Younis,
  • Sally Al Hassan,
  • Issam El Rassi,
  • Munir Obeid,
  • Fadi Bitar,
  • Fadi Bitar,
  • Mariam Arabi,
  • Mariam Arabi

DOI
https://doi.org/10.3389/fcvm.2024.1368921
Journal volume & issue
Vol. 11

Abstract

Read online

AimPulmonary artery banding serves as an important palliative procedure used for the management of several congenital heart lesions. This study aims to describe a 20-year experience of pulmonary artery banding at a tertiary care center in a developing country.MethodsThis is a retrospective chart review of patients who underwent pulmonary artery banding over a 20-year period between January 2000 and July 2020 in a tertiary care center in a developing country. Data regarding demographics, indications, diagnosis, echocardiographic findings, postoperative complications, hospital stay, and outcomes were recorded.ResultsA total of 143 patients underwent pulmonary artery banding between 2000 and 2020, with a decrease from approximately 15 surgeries per year in 2012 to 1–2 surgeries a year in 2020. At the time of banding, the median age of patients was approximately 90 days [interquartile range, IQR, 30–150 days]. Four patients (2.8%) died during the band placement. No significant association was observed between baseline characteristics or type of heart defect at presentation and postoperative morbidity and mortality.ConclusionPulmonary artery banding remains useful in a subset of congenital heart lesions and as a surgical palliation, with relatively low mortality, allowing postponement of total correction to a higher weight. This technique continues to be valuable in developing countries or for heart surgical programs with limited resources.

Keywords